Search Trials
Conditions
Learn
About

Data source: ClinicalTrials.gov

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment | MicrobiomeTrials

← Back to trials

NCT06511518

Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2024-06-03Est. Completion: 2027-06-01

Enrollment target: 56 participants

Locations

Medical Psychology, Amsterdam, North Holland, Netherlands

Contact

Hans Knoop, Prof.hans.knoop@amsterdamumc.nl 020 5666932

Other microbiome trials you might be interested in

Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain MetastasesRecruiting

Brain Metastases, Adult

The purpose of this study is to evaluate the local control rate on the target lesion at 6, 12, and 24 months after treat…

Marseille, FranceEst. completion Jun 30, 2030

View Trial →

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianPhase 1Recruiting

BRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial AdenocarcinomaEstrogen Receptor NegativeHER2/Neu NegativeHigh Grade Ovarian Serous AdenocarcinomaProgesterone Receptor NegativeRecurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7Stage IV Uterine Corpus Cancer AJCC v7Triple-Negative Breast Carcinoma

This phase Ib/II trial studies the side effects and best dose of olaparib and vistusertib (AZD2014) or olaparib and capi…

Houston, United StatesEst. completion Jun 30, 2028

View Trial →

CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced MelanomaPhase 2TERMINATED

MelanomaAdvanced MelanomaMetastatic MelanomaUnresectable Melanoma

CMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monot…

Phoenix, United StatesCompleted Jul 22, 2024

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.